Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 281 | GHRS | GH RESEARCH PLC | Healthcare | 20,920.0 | $294K | 0.08% | +512.0 | +2.5% | $14.06 | +52.1% |
| 282 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 14,755.0 | $293K | 0.08% | +360.0 | +2.5% | $19.89 | -3.0% |
| 283 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 15,166.0 | $291K | 0.08% | +371.0 | +2.5% | $19.20 | -3.0% |
| 284 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 20,815.0 | $289K | 0.08% | +508.0 | +2.5% | $13.90 | -7.5% |
| 285 | MRCC | MONROE CAP CORP | Financial Services | 62,628.0 | $288K | 0.08% | -6K | -8.4% | $4.60 | +10.4% |
| 286 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 80,438.0 | $288K | 0.08% | +2K | +2.5% | $3.58 | -9.2% |
| 287 | PGEN | PRECIGEN INC | Healthcare | 73,899.0 | $286K | 0.08% | +2K | +2.5% | $3.87 | +14.2% |
| 288 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 5,816.0 | $286K | 0.08% | +140.0 | +2.5% | $49.16 | +0.4% |
| 289 | MAIN | MAIN STR CAP CORP | Financial Services | 5,380.0 | $285K | 0.08% | -951.0 | -15.0% | $52.96 | -4.7% |
| 290 | OMER | OMEROS CORP | Healthcare | 26,865.0 | $284K | 0.08% | +653.0 | +2.5% | $10.56 | +16.0% |
| 291 | CYTK | CYTOKINETICS INC | Healthcare | 4,303.0 | $284K | 0.08% | +56.0 | +1.3% | $65.91 | +15.1% |
| 292 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 9,007.0 | $282K | 0.08% | +218.0 | +2.5% | $31.29 | +18.5% |
| 293 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 52,846.0 | $280K | 0.08% | +1K | +2.5% | $5.29 | -65.4% |
| 294 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 16,718.0 | $275K | 0.08% | +408.0 | +2.5% | $16.45 | +10.3% |
| 295 | STOK | STOKE THERAPEUTICS INC | Healthcare | 8,418.0 | $274K | 0.08% | +204.0 | +2.5% | $32.56 | -7.6% |
| 296 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 12,664.0 | $274K | 0.07% | +308.0 | +2.5% | $21.60 | +10.1% |
| 297 | MBX | MBX BIOSCIENCES INC | Healthcare | 9,131.0 | $273K | 0.07% | +221.0 | +2.5% | $29.85 | +8.7% |
| 298 | — | ZYMEWORKS INC | — | 10,702.0 | $268K | 0.07% | +261.0 | +2.5% | $25.04 | — |
| 299 | IRWD | IRONWOOD PHARMACEUTICALS INC | Healthcare | 76,169.0 | $267K | 0.07% | +2K | +2.5% | $3.51 | +2.0% |
| 300 | IMTX | IMMATICS N.V | Healthcare | 27,159.0 | $267K | 0.07% | +662.0 | +2.5% | $9.84 | +10.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%